Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Speciality Retail
  6. /
  7. Cell Point India Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksSpeciality RetailCell Point India Ltd

Cell Point India Ltd Stock Price Today (NSE: CELLPOINT)

Cell Point India Ltd

CELLPOINTSpeciality Retail
₹12.00₹0.45 (3.19%)↓
As on 30 Mar 2026, 12:05 pm ISTMarket Closed

Fundamental Score

...

Cell Point India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Cell Point India Ltd share price today is ₹12.00, down 3.19% on NSE/BSE as of 30 March 2026. Cell Point India Ltd (CELLPOINT) is a Small-cap company in the Speciality Retail sector with a market capitalisation of ₹32.32 (Cr). The 52-week high for CELLPOINT share price is ₹21.15 and the 52-week low is ₹13.35. At a P/E ratio of 38.48x, CELLPOINT is currently trading below its industry average P/E of 39.01x. The company has a Return on Equity (ROE) of 0.51% and a debt-to-equity ratio of 0.90.

Cell Point India Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-3.19%

Returns & Performance

Poor

ROE

0.51%
Poor

ROCE

4.77%
Poor

OPM (5Y)

3.81%

Div Yield

0.00%

Cell Point India Ltd Valuation Check

Average

P/E Ratio

38.48x
Poor

Industry P/E

39.01x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

32.32 (Cr)

Growth Engine

Poor

Profit Growth (Q)

-13.64%
Average

Sales Growth (Q)

15.26%
Poor

Sales Growth (5Y)

2.74%
Poor

EPS Growth (5Y)

-57.37%
Poor

Profit Growth (5Y)

-25.39%

Balance Sheet Health

Poor

Debt to Equity

0.90x
Poor

Int. Coverage

1.07x

Free Cash Flow (5Y)

-23.68 (Cr)

Shareholding

Excellent

Promoter

73.06%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Cell Point Share Price: A Financial Analysis

In the dynamic speciality retail sector, successful expansion often hinges on a brand's ability to cultivate customer loyalty amidst evolving consumer preferences. Understanding the current valuation of companies operating within this niche is crucial for investors. This analysis focuses on the current performance of the Cell Point share price, trading at ₹16.0, and its position relative to its peers. We’ll explore key financial metrics to assess its investment potential.

With a Price-to-Earnings (PE) ratio of 38.48, Cell Point India Ltd suggests a higher valuation compared to some industry standards, indicating investor expectations of future earnings growth. However, its Return on Capital Employed (ROCE) of 4.77% raises concerns. A lower ROCE implies that the company is generating relatively lower profits from its capital investments compared to peers. This impacts the company's economic moat. A weak ROCE signals a reduced ability to sustain competitive advantages or efficiently reinvest profits for future growth.

A crucial aspect often overlooked in financial analysis is management quality. Comparing Cell Point India Ltd with peers like Aditya Vision Limited, we must assess factors such as leadership experience, strategic decision-making, and capital allocation skills. Differences in these areas can significantly influence long-term value creation. For instance, a company with proven operational excellence is more likely to navigate market challenges effectively than one facing internal inefficiencies.

The observed ROCE of 4.77% also prompts a deeper look into the company's cost structure and pricing strategy. Is the company sacrificing margins to gain market share, or are there inherent inefficiencies in its operations? Thorough due diligence necessitates a comprehensive examination of these factors. Ultimately, a high PE ratio combined with a comparatively low ROCE warrants caution. This analysis is part of a detailed 80-parameter fundamental audit personally verified by Sweta Mishra, and provides observations without recommendations and adheres to SEBI guidelines.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Cell Point India Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CELLPOINT across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Strong Revenue Growth (15.26%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Balanced Promoter Holding (73.06%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

10 factors identified

Below-Average Return on Equity (0.51%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (4.77%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (3.81%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Profit Decline Concern (-13.64%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Growth History (2.74% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-57.37% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-25.39% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Weak Interest Coverage (1.07x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-23.68 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Cell Point India Ltd Financial Statements

Comprehensive financial data for Cell Point India Ltd including income statement, balance sheet and cash flow

About CELLPOINT (Cell Point India Ltd)

Cell Point India Ltd (CELLPOINT) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Speciality Retail sector with ...a current market capitalisation of ₹32.32 (Cr). Cell Point India Ltd has delivered a Return on Equity (ROE) of 0.51% and a ROCE of 4.77%. The debt-to-equity ratio stands at 0.90, reflecting the company's capital structure. Investors tracking CELLPOINT share price can monitor key metrics including P/E ratio, promoter holding of 73.06%, and quarterly earnings growth.

Company Details

Symbol:CELLPOINT
Industry:Speciality Retail
Sector:Speciality Retail
Website:N/A

CELLPOINT Share Price: Frequently Asked Questions

What is the current share price of Cell Point India Ltd (CELLPOINT)?

As of 30 Mar 2026, 12:05 pm IST, Cell Point India Ltd share price is ₹12.00. The CELLPOINT stock has a market capitalisation of ₹32.32 (Cr) on NSE/BSE.

Is CELLPOINT share price Overvalued or Undervalued?

CELLPOINT share price is currently trading at a P/E ratio of 38.48x, compared to the industry average of 39.01x. Based on this relative valuation, the Cell Point India Ltd stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of CELLPOINT share price?

The 52-week high of CELLPOINT share price is ₹21.15 and the 52-week low is ₹13.35. These values are updated daily from NSE/BSE price data.

What factors affect the Cell Point India Ltd share price?

Key factors influencing CELLPOINT share price include quarterly earnings growth (Sales Growth: 15.26%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Cell Point India Ltd a good stock for long-term investment?

Cell Point India Ltd shows a 5-year Profit Growth of -25.39% and an ROE of 0.51%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.90 before investing in CELLPOINT shares.

How does Cell Point India Ltd compare with its industry peers?

Cell Point India Ltd competes with major peers in the Speciality Retail. Investors should compare CELLPOINT share price P/E of 38.48x and ROE of 0.51% against the industry averages to determine competitive standing.

What is the P/E ratio of CELLPOINT and what does it mean?

CELLPOINT share price has a P/E ratio of 38.48x compared to the industry average of 39.01x. Investors pay ₹38 for every ₹1 of annual earnings.

How is CELLPOINT performing according to Bull Run's analysis?

CELLPOINT has a Bull Run fundamental score of 19.6/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does CELLPOINT belong to?

CELLPOINT operates in the Speciality Retail industry. This classification helps understand the competitive landscape and sector-specific trends affecting Cell Point India Ltd share price.

What is Return on Equity (ROE) and why is it important for CELLPOINT?

CELLPOINT has an ROE of 0.51%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Cell Point India Ltd generates profits from shareholders capital.

How is CELLPOINT debt-to-equity ratio and what does it indicate?

CELLPOINT has a debt-to-equity ratio of 0.90, which indicates moderate leverage that should be monitored.

What is CELLPOINT dividend yield and is it a good dividend stock?

CELLPOINT offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Cell Point India Ltd shares.

How has CELLPOINT share price grown over the past 5 years?

CELLPOINT has achieved 5-year growth rates of: Sales Growth 2.74%, Profit Growth -25.39%, and EPS Growth -57.37%.

What is the promoter holding in CELLPOINT and why does it matter?

Promoters hold 73.06% of CELLPOINT shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Cell Point India Ltd.

What is CELLPOINT market capitalisation category?

CELLPOINT has a market capitalisation of ₹32 crores, placing it in the Small-cap category.

How volatile is CELLPOINT stock?

CELLPOINT has a beta of N/A. A beta > 1 suggests the Cell Point India Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is CELLPOINT operating profit margin trend?

CELLPOINT has a 5-year average Operating Profit Margin (OPM) of 3.81%, indicating the company's operational efficiency.

How is CELLPOINT quarterly performance?

Recent quarterly performance shows Cell Point India Ltd YoY Sales Growth of 15.26% and YoY Profit Growth of -13.64%.

What is the institutional holding pattern in CELLPOINT?

CELLPOINT has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Cell Point India Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Cell Point India Ltd

What is the current share price of Cell Point India Ltd?

Cell Point India Ltd (CELLPOINT) trades at ₹12.00 on NSE. Market cap ₹32.32 (Cr). Educational data only.

What is the P/E ratio of Cell Point India Ltd?

Cell Point India Ltd has a P/E of 38.48x vs industry average 39.01x.

What is the Bull Run score for Cell Point India Ltd?

Cell Point India Ltd has a Bull Run score of 19.6/100 based on 25+ financial parameters.

Does Cell Point India Ltd pay dividends?

Cell Point India Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Cell Point India Ltd?

Cell Point India Ltd has ROE of 0.51%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Cell Point India Ltd?

Cell Point India Ltd has debt-to-equity of 0.90.

Is Cell Point India Ltd a good investment?

Bull Run gives Cell Point India Ltd a score of 19.6/100. This is not investment advice — consult a SEBI-registered advisor.